Patenting Antibody and Cell Therapies – What to Do and What Not to Do

In Webinars

28 September, 2020

Click here to watch webinar.

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is a complex task, with constantly evolving case law and practice on both sides of the Atlantic. In this webinar, AWA’s experts focus on how to create, defend and litigate these patents in Europe and elsewhere.

 

 

You may also be interested in:

The Business of IP – Understanding and Creating Value: Part 5 – Negotiations

In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or

Read more...

Determining the Value of Patents during an Investment or Sale

Joanna Applequist and Mikael Henriksson speak on IP matters that companies should consider preparing for during an investment or sale during this seminar

Read more...

EPO’s highest legal authority to decide if post-published data can support inventive step

The European Patent Office’s (EPO) highest legal authority, the Enlarged Board of Appeal, is about to be referred questions

Read more...

Mobile Sliding Menu